Propanc Biopharma Inc Quick Ratio (PPCH) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Propanc Biopharma Inc   (PPCH)

Propanc Biopharma Inc 's Quick Ratio

PPCH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.13 above company average Quick Ratio.

Within Major Pharmaceutical Preparations industry 411 other companies have achieved higher Quick Ratio than Propanc Biopharma Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1965 to 3342.

Explain Quick Ratio?
How much Cash & cash equivalents PPCH´s has?
What are PPCH´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PPCH Quick Ratio (Mar 31 2026)
Q3		 (Dec 31 2025)
Q2		 (Sep 30 2025)
Q1		 (Jun 30 2025)
Q4		 (Mar 31 2025)
Q3
Y / Y Current Liabilities Change -19.94 % -12.78 % -12.89 % 47.07 % 17.71 %
Y / Y Cash & cash equivalent Change 774.12 % 3735.42 % 6403.42 % -42.67 % 715.81 %
Quick Ratio MRQ 0.13 0.15 0.17 0 0.01
PPCH's Total Ranking # 3342 # 1965 # 2759 # 3898 # 3909
Seq. Current Liabilities Change -4.09 % 1.44 % -35.96 % 28.5 % 4.48 %
Seq. Cash & cash equivalent Change -20.94 % -6.89 % 4886.24 % -76.19 % 246.89 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 412
Healthcare Sector # 812
Overall Market # 3342


Quick Ratio Statistics
High Average Low
0.29 0.04 0
(Mar 31 2016)   (Mar 31 2014)




Financial Statements
Propanc Biopharma Inc 's Current Liabilities $ 3 Millions Visit PPCH's Balance sheet
Propanc Biopharma Inc 's Cash & cash equivalent $ 0 Millions Visit PPCH's Balance sheet
Source of PPCH's Sales Visit PPCH's Sales by Geography


Cumulative Propanc Biopharma Inc 's Quick Ratio

PPCH's Quick Ratio for the trailling 12 Months

PPCH Quick Ratio

 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -0.85 % 8.76 % 15 % 26.43 % 19.27 %
Y / Y Cash & cash equivalent TTM Growth 1591.73 % 2295.76 % 528.52 % -17.84 % 1.27 %
Quick Ratio TTM 0.1 0.07 0.04 0 0.01
Total Ranking TTM # 4120 # 1930 # 3019 # 3218 # 3486
Seq. Current Liabilities TTM Growth -5.06 % -3.01 % -2.91 % 10.89 % 4.15 %
Seq. Cash & cash equivalent TTM Growth 32.03 % 80.36 % 684.12 % -9.4 % 86.97 %

Quick ratio ranking by company, industry and sector >> Back to PPCH Financial Strength Comparisons >> Go to Compare PPCH Quick Ratio to its Competitors

On the trailing twelve months basis PPCH Cash & cash equivalent more than doubled by 774.12 % in Q3 2026 year on year, while Current Liabilities decreased to $3 millions, this led to increase in in Propanc Biopharma Inc 's Quick Ratio to 0.1, above PPCH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 441 other companies have achieved higher Quick Ratio than Propanc Biopharma Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 1930 to 4120.

Explain Quick Ratio?
How much Cash & cash equivalents PPCH´s has?
What are PPCH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 442
Healthcare Sector # 912
Within the Market # 4120


trailing twelve months Quick Ratio Statistics
High Average Low
0.19 0.03 0
(Sep 30 2016)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Elanco Animal Health Incorporated  0.34 $ 428.000  Millions$ 1,262.000  Millions
Rein Therapeutics Inc   0.33 $ 4.445  Millions$ 13.637  Millions
Cumberland Pharmaceuticals Inc   0.32 $ 11.007  Millions$ 34.488  Millions
Bioxcel Therapeutics Inc   0.31 $ 17.180  Millions$ 54.994  Millions
Cytodyn inc   0.31 $ 15.655  Millions$ 50.428  Millions
Aurinia Pharmaceuticals Inc   0.28 $ 40.749  Millions$ 143.634  Millions
Amneal Pharmaceuticals Inc   0.28 $ 201.830  Millions$ 728.049  Millions
Eli Lilly And Company  0.28 $ 5,282.000  Millions$ 19,087.000  Millions
Teva Pharmaceutical Industries Limited  0.28 $ 3,741.000  Millions$ 13,544.000  Millions
Nrx Pharmaceuticals Inc   0.27 $ 6.713  Millions$ 25.176  Millions
Viatris Inc   0.26 $ 1,804.200  Millions$ 6,810.300  Millions
Ensysce Biosciences Inc   0.26 $ 0.745  Millions$ 2.837  Millions
Akari Therapeutics Plc  0.25 $ 2.768  Millions$ 10.975  Millions
Abbvie Inc   0.22 $ 9,391.000  Millions$ 42,100.000  Millions
Merck and Co Inc   0.21 $ 5,702.000  Millions$ 26,945.000  Millions
Indivior Pharmaceuticals Inc   0.21 $ 175.000  Millions$ 850.000  Millions
Xencor Inc  0.19 $ 14.170  Millions$ 73.457  Millions
International Stem Cell Corporation  0.18 $ 0.933  Millions$ 5.049  Millions
Jaguar Health Inc   0.18 $ 7.278  Millions$ 40.686  Millions
Lunai Bioworks Inc   0.16 $ 3.155  Millions$ 19.283  Millions
Shuttle Pharmaceuticals Holdings Inc   0.13 $ 1.090  Millions$ 8.306  Millions
Propanc Biopharma Inc   0.13 $ 0.444  Millions$ 3.476  Millions
Polomar Health Services, Inc.  0.10 $ 0.097  Millions$ 0.924  Millions
Bioxytran Inc   0.09 $ 0.463  Millions$ 5.010  Millions
Dr Reddy s Laboratories Limited  0.09 $ 164.000  Millions$ 1,787.000  Millions
Citius Pharmaceuticals Inc   0.08 $ 4.590  Millions$ 55.016  Millions
Summit Therapeutics Inc   0.08 $ 8.238  Millions$ 99.075  Millions
Igc Pharma Inc   0.08 $ 0.235  Millions$ 2.873  Millions
Cv Sciences Inc   0.08 $ 0.309  Millions$ 3.799  Millions
Hcw Biologics Inc   0.06 $ 1.229  Millions$ 19.959  Millions

Date modified: 2026-09-08T15:11:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.